EverythingALS Revenue and Competitors
Employee Data
- EverythingALS has 17 Employees.
- EverythingALS grew their employee count by -15% last year.
EverythingALS's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Founder | Reveal Email/Phone |
2 | PR/ Product Coordinator | Reveal Email/Phone |
3 | Lead Data Scientist | Reveal Email/Phone |
EverythingALS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 53 | 2% | N/A | N/A |
#2 | $35M | 132 | 8% | N/A | N/A |
#3 | N/A | 111 | 61% | N/A | N/A |
#4 | $35M | 33 | -3% | N/A | N/A |
#5 | N/A | 25 | -14% | N/A | N/A |
#6 | $3.5M | 82 | 32% | N/A | N/A |
#7 | $3.5M | 32 | -6% | N/A | N/A |
#8 | $7.5M | 289 | 9% | N/A | N/A |
#9 | N/A | 44 | 13% | N/A | N/A |
#10 | $3.5M | 74 | 3% | N/A | N/A |
What Is EverythingALS?
EverythingALS is a patient-focused non-profit bringing technological innovations and data science to support efforts, from care to cure, for people with ALS.We focus on bringing the ALS community knowledge, open data research and to accelerate treatments for ALS.EverythingALS is a brand of Peter Cohen Foundation, 501(c)(3) founded in 2020. We are an actively growing community of ALS patients and caregivers, collaborating with the leading minds at eminent research institutions, conducting IRB approved research into ALS disease progression. We have the largest study in ALS with over 1,000 participants in less than 14 months.Our study is driven by the need for citizen driven research with open innovation platform in digital biomarkers to detect early diagnosis and prognosis of ALS.
keywords:N/AN/A
Total Funding
17
Number of Employees
N/A
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 17 | -11% | N/A |
#2 | $1.5M | 17 | N/A | N/A |
#3 | $1.4M | 17 | N/A | N/A |
#4 | $3.3M | 17 | N/A | N/A |
#5 | $0.5M | 17 | -6% | $29M |